In COVID-19 clinical update #49, Daniel Griffin discusses CDC guidelines on mask use, drop in test frequency in the US, resurgence of COVID-19 in Brazil, possible impact of Pfizer vaccine on viral load, EUA for bamlanivimab and etesevimab administered together, and preliminary results of Tocilizumab in hospitalized patients.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

Resurgence of COVID-19 in Brazil (Lancet)
Pfizer vaccine reduces viral load (medRxiv)
EUA for bamlanivimab plus etesevimab (pdf)
Tocilizumab in hospitalized patients (medRxiv)
Bacterial superinfections in COVID-19 (Open For Inf Dis)
Letters read on TWiV 719
Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

TWiV 719: COVID-19 clinical update #49 with Dr. Daniel Griffin